Brazil's Non-Small-Cell Lung Cancer Drug Market will Reach $240 Million by 2014

Tuesday, July 6, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+

Eli Lilly and Roche Dominated the Non-Small-Cell Lung Cancer Drug Market in Brazil in 2009, According to a New Report from Decision Resources

For more information, contact:

Christopher Comfort

Decision Resources

781-296-2597

[email protected]



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook